THE INTERNATIONAL JOURNAL OF ATHEROSCLEROSIS


Aims and Scope
IJATHERO is a new international peer-reviewed journal of the Department of Atherosclerosis of the Brazilian Society of Cardiology, published quarterly and also available online at <http://www.ijathero.com/>. The journal will publish basic and clinical research related to vascular biology, pathophysiology and complications of atherosclerosis, dyslipidemias, and thrombosis. Some areas of special interest include risk factors for atherosclerosis, coronary artery disease, nutrition, cell and molecular biology, genetics, cardiovascular physiology, morphology, imaging, epidemiology, and related fields such as nephrology, endocrinology, and neuroscience. The journal also aims to provide physicians with continuing education, publishing guidelines and review articles for prevention and treatment of atherosclerosis, dyslipidemias, hypertension, diabetes, and other related areas. The key objective of IJATHERO is to promote high quality science, research and clinical practice in the field of atherosclerosis.


on-line submission
http://publicacoes.cardiol.br/enviodeartigos/eventos.asp or access directly at the end of Instructions for Authors in the home page www.ijathero.com, where also all pertinent information
can be found. It is advisable that the authors submit an abstract to the Editor-in-Chief prior to submitting the full manuscript. The submitted abstract should outline the intended contents and
coverage of their article.

The following types of papers can be submitted:

Basic Research Papers reporting results of original research or investigation, using in vitro, cell culture or animal models.
Clinical Research Papers reporting results of original clinical research or investigation in human subjects.
Review Articles, one per number on a selected topic, are by invitation. An invitation to submit does not guarantee publication. Like original articles submitted to the journal, review articles are subject to peer review.
Rapid Communication. These papers should provide a brief but complete account of important new observations which merit urgent publication. The papers should be less than 5 printed pages (8-10 double-spaced typed pages) including figures and tables and should be concisely but adequately referenced. Authors should state in a covering e-mail why the paper merits urgent publication. Papers requiring revision will not be considered as Rapid Communications. The Editors will normally reach a decision on these papers within one month.
Hypotheses and Viewpoints of up to 1500 words are published occasionally. These contributions are subject to the normal editorial procedure.
Letters to the Editor are welcomed. If the letter is a commentary relating to published work in the journal, the author(s) will have the opportunity to reply in the same issue of the journal.
Letters do not have abstracts and should not exceed 1200 words.
Book Reviews. Short reviews on recently published books of interest to readers in general and specially to experts in the field of atherosclerosis are welcomed.
Announcement meetings, workshops, courses etc. are welcomed, subject to available space.


General Instructions for Manuscripts
Manuscripts should be written in the English language using the American spelling. They should follow the Vancouver Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Updated, October, 2004, www.icmje.org). The number of words per manuscript should not exceed 5000, including title, author names, abstract, main text, figure legends, table legends and acknowledgements. Each table or figure corresponds to 500 words. Thus, an article with one figure and 2 tables should consist of not more than 3,500 words. All words should be counted except for tables, table legends, figure legends and references. If the allowed word count exceeds the established number, this must be explained in an accompanying letter, stating why the author(s) found it necessary to exceed the limit. As a rule research papers should be divided into sections with a heading (e.g. Abstract – structured, up to 250 words-, Introduction, Materials, Patients, Methods, Results, Discussion). A title page should accompany the manuscript. From 3 to 5 keywords should be provided. Authors are encouraged to chose their own keywords, which may repeat words in the title.

Text
a) Follow the General Instructions
b) Abbreviations must be defined at first mention in the text
c) Units of Measurement. Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be in degrees Celsius. Blood pressures should be in millimeter of mercury.
d) Manuscripts that describe studies on humans must indicate that the study was approved by an institutional review committee and the subjects gave informed consent. Reports of studies on both animals and humans must indicate that the procedures followed were in accordance with institutional guidelines.

Acknowledgements
All contributors who do not meet the criteria for authorship should be listed. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Financial and material support should also be acknowledged.

Groups of persons who have contributed materially to the paper but whose contributions do not justify authorship may be listed under a heading such as “clinical investigators” or “participating investigators,” and their function or contribution should be described – for example, “served as scientific advisors,” ”critically reviewed the study proposal,” “collected data,” or “provided and cared for study patients.”.

Because readers may infer their endorsement of the data and conclusions, all persons must give written permission to be acknowledged.
At the end of this section, authors must disclose any and all relationships that could be perceived as real or apparent conflict(s) of interest.

Illustrations/Figures
Figures should be numbered as they appear in the text and provided as pdf, jpg or ppt files. Do not use JPEG or GIF files since they yield poor reproductions. Authors should prepare a plan to show how illustrations, together with their legends, can be laid out neatly on one page.
At the same time you submit your paper on-line, send highcontrast photographic prints of the mentioned figures. The top of all illustrations should be indicated on the reverse, together with the author’s name and number of the figure. Legends for figures should be typed separately and with double spacing and, where relevant, should state magnification.
Line in graphs should be bold enough to be easily read after reduction, as should all symbols used in the figure. Data points are best marked with the following symbols, again assuring that they will be readily distinguishable after reduction: ¡l¨nrp. Important note: In the LEGEND, use words
rather than the symbols; e.g., “black circles = group 1; white squares = group 2; black bars = blood glucose; white bars = C peptide”. Bars should be black or white only, unless more than two data sets are being presented; further bars should be drawn with clear bold hatch marks or stripes, not shades of gray.
Line or bar graphs or flow chars with text should be created in black and white, not shades of gray, which are difficult to reproduce in even tones.
If materials (e.g., figures and tables) are taken from other sources, the author must be able to provide written permission for reproduction obtained from the original publisher and author.

Tables
Tables with titles and legends should be double spaced on separate pages. Tables with internal divisions (Table 1A and B) should be submitted as individual tables, i.e., Tables 1 and 2. Symbols for units should be confined to column headings. Abbreviations should be kept to a minimum and defined in the table legend. For footnotes, use the following symbols consecutively, left to right, top to bottom of table: *, †, ‡, §, ||, #, **, ††

References
References should be given at the end of the paper, numbered in chronological order and quoted in the text at appropriate places. The number of references should not exceed 30 (except for Reviews). They should follow the standard style of the National Library of Medicine and as published in PubMed.

Examples

Duncan BB, Schmidt MI, Pankow Js, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G. Atherosclerosis Risk in Communities Study. Diabetes. 2003 Jul;52(7):1799-805

D’Alessio DA, Vogel R, Prigeion R, Laschansky E, Koerker D, Eng J, Ensinck JW. Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. J Clin Invest 1996 Jan 1;97(1):133-8

Stauffacher W, Renold AK. Pathophysiology of diabetes mellitus. In: Joslin’s Diabetes Mellitus. 11th ed. Marble A, White P, Bradley RF, Krall SP, Eds. Philadelphia: Lea & Febiger; 1971.p. 35-98

Abood S. Quality improvements initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 August 12] 102(6): [about3 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htm

Examples of all other types of references can be found in
www.nlm.nih.gov/bsd/uniform_requirements.html

General
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all Authors and tacitly or
explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher.
Once the author(s) have complied with the outlined instructions, the paper to be analyzed is submitted to a peer review by at least two reviewers. If their opinion is at variance and according to their analysis, it is sent to at least another reviewer. The reviewers’ opinions are sent to the author(s) and their response is again submitted to the reviewers. Only after a favorable answer by the reviewers the paper is accepted.
Upon acceptance of an article, Authors will be asked to transfer copyright. The corresponding form can be accessed at the end of the Instructions in the home page (Copyright Assignment
Agreement and Statement of Originality).
The finished paper should be sent, with a covering e-mail, indicating also the names, addresses, e-mail addresses and phone/fax numbers of four potential reviewers, to the Editor-in-Chief.

Costs to Authors
a) No page charges will be levied to Authors
b) Colored figures can be accepted with additional cost to the author (estimate of cost will be provided by the publisher for Author’s approval)
c) Expense for reprints (price lists are sent with Author’s proof)
d) 50.00 US$ per printed page for excessive author alterations
e) 100.00 US$ per page for printing a correction (erratum) after publication of the article that results from an author’s error

Access to Copyright Assignment Agreement and Statement of Originality, Authors Conflict of Interest Disclosure Questionnaire, Acknowledgement Permission Form and Permissions is available in the home page

In case of any doubt please contact:
Prof. Dr. FAH Fonseca
(Editor-in-Chief)
e-mail: ijathero@cardiol.br
Mailing address:
Sociedade Brasileira de Cardiologia / FUNCOR
Alameda Santos, 705 - 11º andar
01419-001 São Paulo, SP, Brazil
Phone: (55-11) 3262-4378
Fax: (55-11) 3411-5504

back